SCOLIOSIS SOLUTION Trademark

Trademark Overview


On Friday, November 24, 2023, a trademark application was filed for SCOLIOSIS SOLUTION with the United States Patent and Trademark Office. The USPTO has given the SCOLIOSIS SOLUTION trademark a serial number of 98284076. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, June 28, 2024. This trademark is owned by NSite Medical, Inc.. The SCOLIOSIS SOLUTION trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing a website featuring information in the field of indicate, e.g., health, wellness, nutrition, etc
scoliosis solution

General Information


Serial Number98284076
Word MarkSCOLIOSIS SOLUTION
Filing DateFriday, November 24, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, June 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding a website featuring information in the field of indicate, e.g., health, wellness, nutrition, etc

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 16, 2024
Primary Code044
First Use Anywhere DateMonday, October 2, 2023
First Use In Commerce DateSunday, October 8, 2023

Trademark Owner History


Party NameNSite Medical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events


Event DateEvent Description
Tuesday, January 16, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 25, 2024ASSIGNED TO EXAMINER
Friday, June 28, 2024NON-FINAL ACTION E-MAILED
Friday, June 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 28, 2024NON-FINAL ACTION WRITTEN
Tuesday, November 28, 2023NEW APPLICATION ENTERED